Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Proposed acquisition, expected to close in Q4 2025, would add approximately $2 million in annual revenue and increase network ...

Micron changed its guidance today, raising forecasts for revenue and profit. The company earned only $0.70 last year per ...

Micron Technology raised its fourth-quarter revenue and profit forecast on Monday. The move comes as demand for its memory ...

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

Chrono Odyssey, the much-anticipated MMORPG that has faced a year-long delay after a beta phase revealed many issues.

With a profitable and steadily growing business model, along with its involvement in long-term changes in education, Stride’s ...

Beyond the consumer, the August BofA FMS dove into AI trends. A hot topic and a potential bubble, at least according to ...

Super Micro Computer (NASDAQ: SMCI) stock got hit with a wave of selloffs last week in response to the company's latest ...

A small investment today could turn into something big tomorrow. Four hidden altcoins are attracting attention for their ...

The Xpeng X9 is currently available as a pure battery vehicle (BEV). However, through recent Chinese MIT filings, it has been ...

The number of S&P 500 companies mentioning 'recession' in earnings calls has dropped significantly from nearly 125 to under ...